Tony nominee Michael John LaChiusa imagines the inner lives and dreams of America's best-known daughters with a funny and moving follow-up to his 1993 Public musical First Lady Suite. A historical ...

From simple text generation to autonomously powering robotic arms on production lines, AI technology offers enterprises a kaleidoscope of new capabilities. So which aspects of AI advancement have ...

Preteens using increasing amounts of social media perform poorer in reading, vocabulary and memory tests in early adolescence compared with those who use no or little social media. That's according to ...

We frequently define ourselves, largely, by how our early environments define us. Whatever we’re perpetually praised and punished for as children often becomes internalized and generalized. So, if you ...

This story was originally published by the Athens County Independent. MARIETTA, Ohio — After issues with underground migration of toxic fracking waste, the state has established new rules to protect ...

A couple of months ago, I wrote an article on how to use PowerShell to back up a database within SQL Server Express Edition. Even though the technique that I described in that post works, the script ...

Kirsten Ekdahl Hull Named EVP, Portfolio Management; Kori Murphy Named SVP, Region Lead – Retail NEW YORK & SANTA MONICA, Calif.--(BUSINESS WIRE)--Perform Properties (“Perform”), a diversified real ...

Fox News host Brian Kilmeade called for executing homeless individuals with mental health issues during a September 10 episode of Fox & Friends, suggesting "involuntary lethal injection" as a solution ...

In today’s fast-moving work environment, organizations expect teams to do everything at once: perform flawlessly in the moment and constantly improve for the future. But is it wise to ask teams to ...

Artificial intelligence is consuming enormous amounts of energy, but researchers at the University of Florida have built a chip that could change everything by using light instead of electricity for a ...

The FDA has approved a subcutaneous formulation of lecanemab (Leqembi Iqlik, Eisai/Biogen) for maintenance dosing in patients with Alzheimer’s disease (AD) with mild cognitive impairment (MCI) or mild ...